T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.45% |
| 2 | Consumer Discretionary | 13.78% |
| 3 | Financials | 12.98% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.11T
| $11.1B | 2.41% |
380,361,684
+4,642,531
| +1% | +$134M |
|
2
Amazon
AMZN
$2.44T
| $7.29B | 1.59% |
452,117,240
-16,004,460
| -3% | -$266M |
|
|
3
Gilead Sciences
GILD
$165B
| $6.27B | 1.37% |
58,913,323
-8,083,294
| -12% | -$792M |
|
|
4
Visa
V
$677B
| $5.72B | 1.25% |
107,178,332
+13,032,520
| +14% | +$700M |
|
5
Booking.com
BKNG
$156B
| $5.62B | 1.23% |
121,215,975
+2,477,100
| +2% | +$122M |
|
6
Danaher
DHR
$138B
| $5.46B | 1.19% |
106,943,778
+6,128,097
| +6% | +$315M |
|
7
Boeing
BA
$169B
| $4.94B | 1.08% |
38,789,102
+2,007,894
| +5% | +$253M |
|
8
Apple
AAPL
$4.97T
| $4.55B | 0.99% |
180,501,084
-26,925,836
| -13% | -$661M |
|
9
McKesson
MCK
$104B
| $4.43B | 0.97% |
22,756,410
+328,918
| +1% | +$63.3M |
|
10
Baidu
BIDU
$35.7B
| $4.3B | 0.94% |
19,726,672
+730,741
| +4% | +$154M |
|
11
Biogen
BIIB
$30.9B
| $4.23B | 0.92% |
12,791,052
+596,411
| +5% | +$197M |
|
12
JPMorgan Chase
JPM
$916B
| $4.08B | 0.89% |
67,665,740
-3,423,115
| -5% | -$200M |
|
13
Meta Platforms (Facebook)
META
$1.49T
| $3.88B | 0.85% |
49,077,733
+5,212,562
| +12% | +$382M |
|
|
PXD
14
DELISTED
Pioneer Natural Resource Co.
PXD
| $3.77B | 0.82% |
19,130,002
+1,899,650
| +11% | +$402M |
|
15
GE Aerospace
GE
$364B
| $3.6B | 0.79% |
29,347,217
+2,655,301
| +10% | +$331M |
|
16
RTX Corp
RTX
$290B
| $3.39B | 0.74% |
50,990,071
-2,151,333
| -4% | -$148M |
|
|
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.27B | 0.71% |
19,708,654
+2,405,193
| +14% | +$395M |
|
|
AGN
18
DELISTED
Allergan Inc
AGN
| $3.25B | 0.71% |
18,217,009
+2,297,605
| +14% | +$382M |
|
|
19
American Airlines Group
AAL
$9.82B
| $3.13B | 0.68% |
88,088,808
+15,909,770
| +22% | +$626M |
|
20
Lowe's Companies
LOW
$121B
| $3.11B | 0.68% |
58,688,235
+1,052,038
| +2% | +$53.2M |
|
21
UnitedHealth
UNH
$382B
| $3B | 0.65% |
34,765,661
-1,556,290
| -4% | -$132M |
|
|
PCP
22
DELISTED
PRECISION CASTPARTS CORP
PCP
| $2.88B | 0.63% |
12,175,662
-968,967
| -7% | -$235M |
|
23
Morgan Stanley
MS
$319B
| $2.87B | 0.63% |
82,918,752
+10,107,899
| +14% | +$337M |
|
24
American Tower
AMT
$83.5B
| $2.86B | 0.62% |
30,495,495
-4,328,403
| -12% | -$412M |
|
|
25
Wynn Resorts
WYNN
$10.3B
| $2.83B | 0.62% |
15,118,950
+5,023,324
| +50% | +$992M |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.